Gerontopsychiatry Focus on polypharmacy – challenges and solutions CME continuing education Education Geriatrics Partner Content Pharmacology and toxicology Psychiatry and psychotherapy RX Studies View Post
View Post This content is machine translated Geriatric Psychiatry Increased patient numbers, effective treatment The results of the ANQ quality measurements in Swiss psychiatric clinics show the extent to which patients’ symptom burden decreased during inpatient treatment in 2023. The use of measures that restrict freedom was also surveyed. For the first time, the ANQ is reporting the results of geriatric psychiatry separately. View Post
View Post This content is machine translated PUBLIC REPORT Ginkgo biloba – a miracle cure for cognitive brain disorders and dementia? Although in relative terms dementia is slightly decreasing in the population, in absolute terms we are encountering more and more people with dementia due to the increase in life expectancy with associated risk of brain disorders. Pharmacologically, there have been few therapeutic options to date; for example, antidementia drugs such as donepezil, memantine, and others have hardly lived up to their promise. Read the report by Prof. Peter E. Ballmer, MD, on the topic. View Post
View Post This content is machine translated Online training Dementia: benefits of early treatment despite COVID-19 The Corona pandemic presents unique challenges for people with a psychiatric condition. Prof. Dr. med. Egemen Savaskan from the Psychiatric University Hospital Zurich informs about the state of the art in geriatric psychiatry, what is now important in the care of patients with psychiatric clinical pictures and why family doctors have an elementary role in the (early) diagnosis of dementia. View Post
